Mon, January 30, 2012
[ Mon, Jan 30th 2012 ] - Market Wire
Revaskularisierungsgert von Covidien zur interven .. llen Behandlung bei Schlaganfallstudie zugelassen
[ Mon, Jan 30th 2012 ] - Market Wire
Compugen Presents Three Product Candidates for Tr .. s at the Immunotherapeutics & Immunomonitoring Co
[ Mon, Jan 30th 2012 ] - Market Wire
Dispositivo per la rivascolarizzazione di Covidie .. tazione interventistica sulla gestione dell'ictus
[ Mon, Jan 30th 2012 ] - Market Wire
Implant Sciences Sells Explosives Trace Detection Units for Deployment in Africa
[ Mon, Jan 30th 2012 ] - Market Wire
DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases
[ Mon, Jan 30th 2012 ] - Market Wire
Capital Senior Living Corporation to Present at U .. are Services Conference on Wednesday, February 8,
[ Mon, Jan 30th 2012 ] - Market Wire
Wright Medical Group, Inc. Names Daniel Garen Senior Vice President and Chief Compliance Officer
Sat, January 28, 2012
[ Sat, Jan 28th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Health Management Associates, Inc.
[ Sat, Jan 28th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.
Fri, January 27, 2012
[ Fri, Jan 27th 2012 ] - Market Wire
Medisafe 1 Technologies Announces $1MM Stock Repu .. ase Program of 10MM Shares up to 10 Cents a Share
[ Fri, Jan 27th 2012 ] - Market Wire
Bionovo to Voluntarily Delist from NASDAQ
[ Fri, Jan 27th 2012 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in TranS1, Inc. to Inquire About the Le
[ Fri, Jan 27th 2012 ] - Market Wire
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
[ Fri, Jan 27th 2012 ] - Market Wire
Illuminaas Board of Directors to Review Unsolicited Tender Offer from Roche
[ Fri, Jan 27th 2012 ] - Market Wire
ZOLL Medical, Vistaprint NV, Corning, Apple and Google
[ Fri, Jan 27th 2012 ] - Market Wire
BIOLASE Signs Strategic Sales and Marketing Partn .. udy Club, a Leading Dental Education Organization
[ Fri, Jan 27th 2012 ] - Market Wire
Medtronic Launches New Minimally Invasive Cardiac .. lusive Distribution Agreement with Miami Instrume
[ Fri, Jan 27th 2012 ] - Market Wire
Boston Scientific, Sirius, Momenta Pharmaceuticals, Gran Tierra Energy, Taseko Mines and TiVo
[ Fri, Jan 27th 2012 ] - Market Wire
Reduce Stress and Help Shoo the Flu
[ Fri, Jan 27th 2012 ] - Market Wire
Centene Corporation to Present at UBS 2012 Healthcare Conference
[ Fri, Jan 27th 2012 ] - Market Wire
CooperVisiona" Helps the Association for the Blind and Visually Impaired
[ Fri, Jan 27th 2012 ] - Market Wire
Tornier Announces 2011 Fourth Quarter and Full Year Conference Call
[ Fri, Jan 27th 2012 ] - Market Wire
WellPoint Launches Innovative Reimbursement Initi .. y Care Physicians to Improve Quality and Reduce M
[ Fri, Jan 27th 2012 ] - Market Wire
GenVec Extends Research Collaboration with Global Pharmaceutical Company
[ Fri, Jan 27th 2012 ] - Market Wire
iBio, Inc. Listing Deficiency Resolved
[ Fri, Jan 27th 2012 ] - Market Wire
Infinity Reports Update from Phase 2 Study of Sar .. ine in Patients with Metastatic Pancreatic Cancer
[ Fri, Jan 27th 2012 ] - Market Wire
El estudio ASCEND evaluar la eficacia de TYSABRI .. o para la esclerosis mltiple secundaria progresiv
[ Fri, Jan 27th 2012 ] - Market Wire
Independent Data Published on BioLife Solutions HypoThermosol and CryoStor
[ Fri, Jan 27th 2012 ] - Market Wire
Dr. Reddyas Clarifies Media Reports
Thu, January 26, 2012
[ Thu, Jan 26th 2012 ] - Market Wire
Aetna Announces Transaction with Vitality Re III
[ Thu, Jan 26th 2012 ] - Market Wire
Theratechnologies to Announce Results for Its 2011 Fiscal Year
[ Thu, Jan 26th 2012 ] - Market Wire
Vista Partners Updates Coverage on OncoSec Medical Inc.;; Target Price $2.50
[ Thu, Jan 26th 2012 ] - Market Wire
Align Technology, Zeltiq Aesthetics & Others
[ Thu, Jan 26th 2012 ] - Market Wire
Align Technology, Zeltiq Aesthetics amp;; Others
[ Thu, Jan 26th 2012 ] - Market Wire
BioReference to Launch Groundbreaking Solid Tumor .. ping Test through its GenPath Oncology Laboratory
[ Thu, Jan 26th 2012 ] - Market Wire
Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors
[ Thu, Jan 26th 2012 ] - Market Wire
Merck to Hold 2011 Full-Year and Fourth-Quarter Sales and Earnings Conference Call on February 2
[ Thu, Jan 26th 2012 ] - Market Wire
Lo studio ASCEND valuter l'efficacia di TYSABRI ( .. o per la sclerosi multipla secondariamente progre
[ Thu, Jan 26th 2012 ] - Market Wire
tude ASCEND pour valuer l'efficacit de TYSABRI (n .. ement pour la sclrose en plaques progressive seco
[ Thu, Jan 26th 2012 ] - Market Wire
ASCEND-Studie zur Prfung der Wirksamkeit von TYSA .. herapie fr sekundr-progrediente Multiple Sklerose
[ Thu, Jan 26th 2012 ] - Market Wire
ASCEND Study to Evaluate the Effectiveness of TYS .. ment for Secondary-Progressive Multiple Sclerosis
[ Thu, Jan 26th 2012 ] - Market Wire
Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimeras Care
[ Thu, Jan 26th 2012 ] - Market Wire
NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign
[ Thu, Jan 26th 2012 ] - Market Wire
Celgene to Acquire Avila Therapeutics
[ Thu, Jan 26th 2012 ] - Market Wire
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX Phase Ib Cellulite Study
[ Thu, Jan 26th 2012 ] - Market Wire
Nutraceutical Reports Fiscal 2012 Q1 Results
[ Thu, Jan 26th 2012 ] - Market Wire
Soligenix Receives $574,000 in Non-Dilutive Finan .. hnology Business Tax Certificate Transfer Program
[ Thu, Jan 26th 2012 ] - Market Wire
Initial Clinical Data Reveal Potential of Tasimel .. the Body Clock in Non-24-Hour Sleep-Wake Disorder
[ Thu, Jan 26th 2012 ] - Market Wire
Illumina Adopts Stockholder Rights Agreement
Wed, January 25, 2012
[ Wed, Jan 25th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of TranS1 Inc.
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead start een Fase 2 klinisch onderzoek voor d .. n lage-dosis nieuwe prodrug van Tenofovir voor de
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead avvia una sperimentazione clinica di Fase .. 340, un nuovo profarmaco di tenofovir a basso dos
[ Wed, Jan 25th 2012 ] - Market Wire
Law Firm Brower Piven Announces Investigation in .. e Possible Acquisition of Illumina, Inc. by Roche
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead inicia ensayo clnico de Fase 2 que evala G .. e baja dosis de tenofovir para el tratamiento del
[ Wed, Jan 25th 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Illumina Inc.
[ Wed, Jan 25th 2012 ] - Market Wire
Thoratec Schedules Fourth Quarter Conference Call, Webcast
[ Wed, Jan 25th 2012 ] - Market Wire
Investigation of Chemed Corporation Shareholder Claims by Goldfarb Branham Law Firm LLP
[ Wed, Jan 25th 2012 ] - Market Wire
ZELTIQ spant rechtszaak aan tegen Clinipro wegens patentinbreuk
[ Wed, Jan 25th 2012 ] - Market Wire
Neurocrine Biosciences Announces The FDA Has Gran .. t Track Designation For VMAT2 Inhibitor NBI-98854
[ Wed, Jan 25th 2012 ] - Market Wire
Medtronic and Guided Therapeutics Poised for Growth
[ Wed, Jan 25th 2012 ] - Market Wire
Antares Pharma and Boston Scientific Benefit From Renewed Industry Optimism
[ Wed, Jan 25th 2012 ] - Market Wire
Digirad Receives CE Mark Approval for Advanced, Solid-State Cardius(R) X-ACT Imaging System
[ Wed, Jan 25th 2012 ] - Market Wire
ZELTIQ Initiates Patent Infringement Lawsuit Against Clinipro
[ Wed, Jan 25th 2012 ] - Market Wire
Dados Clnicos para o Estudo da DURABILIDADE II Apresentado na ISET 2012
[ Wed, Jan 25th 2012 ] - Market Wire
Donnes cliniques pour l'tude DURABILITY II prsente lors de l'ISET 2012
[ Wed, Jan 25th 2012 ] - Market Wire
FDA actualiseert TYSABRI (natalizumab) label en v .. s antilichaam status toe als een PML risicofactor
[ Wed, Jan 25th 2012 ] - Market Wire
Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508
[ Wed, Jan 25th 2012 ] - Market Wire
DaVita Acquires Majority Stake in NephroLife India
[ Wed, Jan 25th 2012 ] - Market Wire
Cord Blood America Reports that Umbilical Cord Bl .. Used in Experimental Effort to Treat Type 1 Diabe
Tue, January 24, 2012
[ Tue, Jan 24th 2012 ] - Market Wire
Quarterly Report I 11/12
[ Tue, Jan 24th 2012 ] - Market Wire
Codexis Announces CFO Departure
[ Tue, Jan 24th 2012 ] - Market Wire
Mylan to Host Investor Day on Feb. 21, 2012, in New York City
[ Tue, Jan 24th 2012 ] - Market Wire
Oramed Pharmaceuticals Granted Australian Patent .. pany's Core Technology in Oral Delivery of Protei
[ Tue, Jan 24th 2012 ] - Market Wire
Cleveland BioLabs Announces Management Reorganization
[ Tue, Jan 24th 2012 ] - Market Wire
Critical Outcome Technologies Inc. Initiates Preclinical Testing of AML Drug Candidates
[ Tue, Jan 24th 2012 ] - Market Wire
Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors
[ Tue, Jan 24th 2012 ] - Market Wire
Booming Stem Cell Market Benefits Advanced Cell Technology and Neostem
[ Tue, Jan 24th 2012 ] - Market Wire
Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry
[ Tue, Jan 24th 2012 ] - Market Wire
Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients
[ Tue, Jan 24th 2012 ] - Market Wire
Adipose Stem Cell Heart Attack Trial Data Publish .. College of Cardiology;; Cytori's APOLLO T
[ Tue, Jan 24th 2012 ] - Market Wire
Spectranetics Strengthens Peripheral Vascular Por .. a Partnership to Distribute the TAPASa" Catheter
[ Tue, Jan 24th 2012 ] - Market Wire
BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C
[ Tue, Jan 24th 2012 ] - Market Wire
PDL BioPharma Announces 2012 Regular Quarterly Dividends
[ Tue, Jan 24th 2012 ] - Market Wire
Quest Diagnostics Increases Share Repurchase Authority by $1 Billion
[ Tue, Jan 24th 2012 ] - Market Wire
Covidien verffentlicht klinische Daten ber Plaque-Exzision zur Behandlung kalzifizierter Lsionen
[ Tue, Jan 24th 2012 ] - Market Wire
TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City
[ Tue, Jan 24th 2012 ] - Market Wire
OncoSec to Present at World Cancer Immunotherapy Conference
[ Tue, Jan 24th 2012 ] - Market Wire
Dhr. Richard W. Barker wordt lid Raad van Bestuur van Celgene Corporation
Mon, January 23, 2012
[ Mon, Jan 23rd 2012 ] - Market Wire
Revoici la dpche corrige : Celgene Corporation li .. W. Barker, D. Phil., son conseil d'administration
[ Mon, Jan 23rd 2012 ] - Market Wire
Celgene Corporation incorpora a su Consejo de Administracin al Dr. Richard W. Barker
[ Mon, Jan 23rd 2012 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc.
[ Mon, Jan 23rd 2012 ] - Market Wire
Fresh Start Private Renews Advertising Agreement With Clear Channel Los Angeles Until 2013
[ Mon, Jan 23rd 2012 ] - Market Wire
UnitedHealth Group, The Goldman Sachs, Tiffany & Company, News Corporation and School Specialty
[ Mon, Jan 23rd 2012 ] - Market Wire
Verisante Aura Clinical Study Data Analysis Presented at SPIE
[ Mon, Jan 23rd 2012 ] - Market Wire
Radient Pharmaceuticals Presented Two Abstracts a .. testinal Cancers Symposium (ASCO) on Jan 21, 2012
[ Mon, Jan 23rd 2012 ] - Market Wire
OPKO Health Acquires Next Generation Prostate Cancer Tests
[ Mon, Jan 23rd 2012 ] - Market Wire
Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board
[ Mon, Jan 23rd 2012 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
[ Mon, Jan 23rd 2012 ] - Market Wire
Canada's First National Public Cord Blood Bank Ad .. ThermoGenesis BioArchive Cryopreservation System
[ Mon, Jan 23rd 2012 ] - Market Wire
MyMedicalRecords to Introduce Mobile Phone and Tablet App at HIMSS
[ Mon, Jan 23rd 2012 ] - Market Wire
Boston Scientific Announces Favorable Ruling in Patent Infringement Case
[ Mon, Jan 23rd 2012 ] - Market Wire
Amarantus BioSciences Licenses Parkinsonas Diseas .. ostic Biomarker Test from Power3 Medical Products
[ Mon, Jan 23rd 2012 ] - Market Wire
The Medicines Company Settles Angiomax(R) (Bivali .. udin) Patent Litigations With App Pharmaceuticals
[ Mon, Jan 23rd 2012 ] - Market Wire
EntreMed Secures $10 Million Strategic Financing
[ Mon, Jan 23rd 2012 ] - Market Wire
Marina Biotech Receives Notice of Acceptance for .. g Its Unlocked Nucleobase Analog (UNA) Technology
[ Mon, Jan 23rd 2012 ] - Market Wire
BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
[ Mon, Jan 23rd 2012 ] - Market Wire
PAREXEL Expands Alliance Network to Support Early .. lishes Collaboration With University Hospitals Br
Sun, January 22, 2012
[ Sun, Jan 22nd 2012 ] - Market Wire
Helix BioPharma Corp. Responds to Dissident Proxy .. ion With the January 30, 2012 Shareholder Meeting
Sat, January 21, 2012
[ Sat, Jan 21st 2012 ] - Market Wire
L'FDA aggiorna l'etichetta del TYSABRI (natalizum .. egli anticorpi anti-JCV come fattore di rischio d
[ Sat, Jan 21st 2012 ] - Market Wire
FDA aktualisiert Produktinformationen fr TYSABRI .. des JC-Virus-Antikrperstatus als Risikofaktor fr
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l' .. zumab) pour y inclure le statut daanticorps anti-
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. de TYSABRI (natalizumab) pour y inclure le statut
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;tiquetage de TYSABRI (natalizumab) p
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;tiquetage de TYSABRI (na
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;tiquetage de TYS
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;tiquetage de
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;tiquetag
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;tiqu
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
Fri, January 20, 2012
[ Fri, Jan 20th 2012 ] - Market Wire
Select Medical Holdings Corporation to Announce F .. d Full Year 2011 Results on Thursday, February 23
[ Fri, Jan 20th 2012 ] - Market Wire
FDA Advisory Committee Declines to Recommend Appr .. Gel 8% for the Reduction of Risk of Preterm Birth
[ Fri, Jan 20th 2012 ] - Market Wire
FDA Updates TYSABRI (natalizumab) Label to Includ .. nti-JC Virus Antibody Status as a PML Risk Factor
[ Fri, Jan 20th 2012 ] - Market Wire
Exelixis Reports Positive Preliminary Phase 2 Cab .. ib Data in Patients with Hepatocellular Carcinoma
[ Fri, Jan 20th 2012 ] - Market Wire
Bestuursvoorzitter van Covidien gekozen tot Voorzitter van de Raad
[ Fri, Jan 20th 2012 ] - Market Wire
Waters and NIBRT Complete Work on World's First UPLC Glycan Database
[ Fri, Jan 20th 2012 ] - Market Wire
Sequenom Prices Public Offering of Common Stock
[ Fri, Jan 20th 2012 ] - Market Wire
Amerigroup Corporation to Discuss Fourth Quarter Earnings on February 17
[ Fri, Jan 20th 2012 ] - Market Wire
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
[ Fri, Jan 20th 2012 ] - Market Wire
Hartford Hospital Selected as a Hansen Medical "C .. llence" for Sensei(R) X Robotic Catheter Platform
[ Fri, Jan 20th 2012 ] - Market Wire
Genomic Health Presents Results From First Clinic .. ncotype DX Colon Cancer at the 2012 Gastrointesti
[ Fri, Jan 20th 2012 ] - Market Wire
Insmed Incorporated Provides Corporate Update
[ Fri, Jan 20th 2012 ] - Market Wire
INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA
[ Fri, Jan 20th 2012 ] - Market Wire
Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN
[ Fri, Jan 20th 2012 ] - Market Wire
Director general de Covidien designado presidente del Directorio
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien CEO Elected Chairman of the Board
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien: amministartore delegato eletto presidente del consiglio d'amministrazione
[ Fri, Jan 20th 2012 ] - Market Wire
Le PDG de Covidien est lu prsident du conseil daadministration
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien-CEO zum Chairman of the Board gewhlt
Thu, January 19, 2012
[ Thu, Jan 19th 2012 ] - Market Wire
Bull amp;; Lifshitz, LLP Announces Investigation of Inhibitex, Inc.
[ Thu, Jan 19th 2012 ] - Market Wire
Cannabis Science Updates Second Medical Cannabis .. Squamous Cell Carcinoma Photo-documents Cannabis
[ Thu, Jan 19th 2012 ] - Market Wire
Holzer Holzer & Fistel, LLC Announces Investigati .. Breaches of Fiduciary Duty by Certain Officers an
[ Thu, Jan 19th 2012 ] - Market Wire
Au vu des rsultats positifs d'une analyse intermd .. surveillance et de scurit de l'tude clinique FAME
[ Thu, Jan 19th 2012 ] - Market Wire
Tenet Announces New Agreement with Blue Cross and Blue Shield of Illinois
[ Thu, Jan 19th 2012 ] - Market Wire
Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
[ Thu, Jan 19th 2012 ] - Market Wire
Novo Nordisk Named to FORTUNE'S '100 Best Companies to Work For' List for Fourth Consecutive Year
[ Thu, Jan 19th 2012 ] - Market Wire
Catalina Council Boy Scouts Partner With Sanofi U .. to Host First-Ever Chemistry Merit Badge Program
[ Thu, Jan 19th 2012 ] - Market Wire
ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
[ Thu, Jan 19th 2012 ] - Market Wire
Magellan Health Services and Phoenix Health Plan Announce Joint Venture Development Agreement
[ Thu, Jan 19th 2012 ] - Market Wire
Community Health Systems, Inc. Announces Its Inte .. ent of Its Existing Credit Agreement and Extensio
[ Thu, Jan 19th 2012 ] - Market Wire
ARCA biopharma Announces Additional Patent Issued .. ment with Bucindolol Based on Genotype of Patient
[ Thu, Jan 19th 2012 ] - Market Wire
OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium
[ Thu, Jan 19th 2012 ] - Market Wire
Nordion Enters Six-Year Cobalt-60 Supply Agreement with Synergy Health
[ Thu, Jan 19th 2012 ] - Market Wire
Mindray Medical to Exhibit at Arab Health 2012 in Dubai from January 23-26
[ Thu, Jan 19th 2012 ] - Market Wire
Implant Sciences' Quantum Sniffer QS-H150 Deployed at Major International Bank in Middle East
[ Thu, Jan 19th 2012 ] - Market Wire
Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012
[ Thu, Jan 19th 2012 ] - Market Wire
Adeona Announces Initiation of Phase II Clinical .. " for Cognitive Dysfunction in Multiple Sclerosis
[ Thu, Jan 19th 2012 ] - Market Wire
Kraig Biocraft Laboratories Announces New CEO Interview
Wed, January 18, 2012
[ Wed, Jan 18th 2012 ] - Market Wire
Magellan Health Services Announces Fourth Quarter 2011 Earnings Conference Call
[ Wed, Jan 18th 2012 ] - Market Wire
Astellas und XenoPort geben japanische Zulassung .. ite-Tabletten gegen Restless-Legs-Syndrom bekannt
[ Wed, Jan 18th 2012 ] - Market Wire
Bond Labs Launches Innovative New Product Stack
[ Wed, Jan 18th 2012 ] - Market Wire
Brain Cancer Patient Receives First TrueBeam STx .. ment in Asia at BGS Global Hospitals in Bangalore
[ Wed, Jan 18th 2012 ] - Market Wire
Hansen Medical to Showcase Magellan(TM) Robotic System at Leipzig Interventional Course
[ Wed, Jan 18th 2012 ] - Market Wire
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
[ Wed, Jan 18th 2012 ] - Market Wire
Cynosure to Host Fourth-Quarter 2011 Financial Results Conference Call on February 14
[ Wed, Jan 18th 2012 ] - Market Wire
Comprehensive Care Corp. (CHCR) Completes Its Network Across Puerto Rico
[ Wed, Jan 18th 2012 ] - Market Wire
Prestige Brands, Inc. Announces Offering of $290 Million Senior Notes
[ Wed, Jan 18th 2012 ] - Market Wire
Gilead Sciences perfeziona laacquisizione di Pharmasset, Inc.
[ Wed, Jan 18th 2012 ] - Market Wire
Abschluss der bernahme von Pharmasset, Inc., durch Gilead Sciences
[ Wed, Jan 18th 2012 ] - Market Wire
Gilead Sciences completa adquisicin de Pharmasset, Inc.
[ Wed, Jan 18th 2012 ] - Market Wire
Biomerica Announces Second Quarter Financial Results
[ Wed, Jan 18th 2012 ] - Market Wire
Given Imaging to Host Fourth Quarter and Full-Year 2011 Financial Results Conference Calls
[ Wed, Jan 18th 2012 ] - Market Wire
Soligenix Demonstrates Robust Stability Results with its SGX204 Anthrax Vaccine
[ Wed, Jan 18th 2012 ] - Market Wire
Bioline Introduces HyperPAGE II Broad Range Prestained Protein Marker
[ Wed, Jan 18th 2012 ] - Market Wire
MedPro Safety Products to Participate in Key European, US Industry Conferences
[ Wed, Jan 18th 2012 ] - Market Wire
OncoSec Provides Company Update and Announces 2012 Goals
[ Wed, Jan 18th 2012 ] - Market Wire
Perceptive Informatics Medical Imaging Services Receive Top Ratings
Tue, January 17, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Gilead Sciences Completes Acquisition of Pharmasset, Inc.
[ Tue, Jan 17th 2012 ] - Market Wire
The Medicines Company's Cangrelor Bridge Trial Pu .. n the Journal of the American Medical Association
[ Tue, Jan 17th 2012 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. rnings Release Date for Tuesday, February 7, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Kensey Nash Corporation Announces Its Second Quar .. ear 2012 Earnings Release Date and Teleconference
[ Tue, Jan 17th 2012 ] - Market Wire
Graymark Healthcare Partners With Emory Universit .. anta, Georgia to Deliver Comprehensive Sleep Care
[ Tue, Jan 17th 2012 ] - Market Wire
Johnson & Johnson to Host Analyst Meeting to Disc .. urth-Quarter and Full-Year 2011 Financial Results
[ Tue, Jan 17th 2012 ] - Market Wire
Johnson amp;; Johnson to Host Analyst Meet .. urth-Quarter and Full-Year 2011 Financial Results
[ Tue, Jan 17th 2012 ] - Market Wire
Alnylam Files Patent Infringement Suit Against Tekmira
[ Tue, Jan 17th 2012 ] - Market Wire
Cleveland BioLabs Publishes Manuscript on New Radiation Countermeasure CBLB613
[ Tue, Jan 17th 2012 ] - Market Wire
Cytomedix Appoints Cathryn Hope as Vice President of Marketing
[ Tue, Jan 17th 2012 ] - Market Wire
ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan
[ Tue, Jan 17th 2012 ] - Market Wire
Palatin Technologies Receives $1.1 Million From Sale of New Jersey State Tax Credits
[ Tue, Jan 17th 2012 ] - Market Wire
MAP Pharmaceuticals Appoints W. James O'Shea to Board of Directors
[ Tue, Jan 17th 2012 ] - Market Wire
Akorn Provides Financial Guidance for 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Medivation and Pfizer Announce Results From Phase .. 3 Concert Trial of Dimebon in Alzheimer's Disease
[ Tue, Jan 17th 2012 ] - Market Wire
Illumina to Announce Fourth Quarter and Fiscal Ye .. 11 Financial Results on Tuesday, January 31, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Health Management Associates, Inc. Provides Addit .. to Recently Announced General Counsel Resignation
[ Tue, Jan 17th 2012 ] - Market Wire
OncoSec Medical President and CEO Contributes to Drug Discovery News
[ Tue, Jan 17th 2012 ] - Market Wire
PAREXEL Appoints Former Senior FDA Official David .. er to Global Team of Strategic Compliance Experts
Mon, January 16, 2012
[ Mon, Jan 16th 2012 ] - Market Wire
ISTA's Board of Directors to Review Valeant's Rev .. s Part of Its Ongoing Review of Strategic Options

ERRATA CORRIGE: Richard W. Barker eletto nel Consiglio d'amministrazione di Celgene Corporation


//health-fitness.news-articles.net/content/2012/ .. io-d-amministrazione-di-celgene-corporation.html
Published in Health and Fitness on Monday, January 23rd 2012 at 9:02 GMT by Market Wire   Print publication without navigation


SUMMIT, NEW JERSEY--([ ])--Celgene Corporation (NASDAQ: CELG) ha annunciate oggi la nomina di Richard W. Barker, D.Phil., a membro del Consiglio d'amministrazione. Barker un opinion leader riconosciuto a livello mondiale nell'ambito dei sistemi sanitari e delle politiche sanitarie nazionali. Ha ricoperto il ruolo di Direttore generale dell'Associazione dell'industria farmaceutica Britannica (ABPI) e di membro del Consiglio d'amministrazione per le associazioni europee ed internazionali dell'industria farmaceutica, occupandosi di questioni cruciali e lavorando a stretto contatto con le agenzie governative per la salute.

Nella sua carriera Barker stato CEO di Chiron Diagnostics, Direttore generale del reparto di IBM dedicato alle soluzioni sanitarie e responsabile del centro di competenza Sanit per l'Europa di McKinsey & Company.

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.


Publication Contributing Sources